{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:48:53Z","timestamp":1791294533257,"version":"4.1.0"},"reference-count":83,"publisher":"Oxford University Press (OUP)","issue":"1029","license":[{"start":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T00:00:00Z","timestamp":1301011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>There are no existing guidelines supporting the withdrawal or continuation of renin\u2013angiotensin\u2013aldosterone system (RAAS) antagonists in the preoperative setting. RAAS antagonists include ACE inhibitors, angiotensin II receptor subtype 1 blockers and direct renin inhibitors (eg, aliskiren), as well as the aldosterone antagonists. The use of these agents before surgery has been associated with a variable incidence of hypotension during the initial 30\u2005min after induction of anaesthesia; however, these hypotensive episodes have not been conclusively linked to any significant postoperative complications, although recent data suggest an increase in postoperative morbidity and mortality in patients undergoing coronary artery bypass grafting. Further studies are required to be able to demonstrate if the organ-protective benefits of RAAS antagonists justify their continuation in the perioperative setting. Temporary withdrawal of RAAS antagonists in these patients may prevent or attenuate intraoperative hypotension and hypovolaemia. Alternatively, the increase in RAAS activity and blood pressure expected with cessation of RAAS antagonist therapy may impair regional circulation secondary to an increase in systemic vascular resistance. Full discussion of the potential implications of perioperative RAAS antagonist therapy with the surgical team is important, and strategies to ensure careful monitoring and maintenance of adequate intravenous volume before induction of anaesthesia are essential.<\/jats:p>","DOI":"10.1136\/pgmj.2010.112987","type":"journal-article","created":{"date-parts":[[2011,3,26]],"date-time":"2011-03-26T00:15:21Z","timestamp":1301098521000},"page":"472-481","source":"Crossref","is-referenced-by-count":56,"title":["Renin\u2013angiotensin system antagonists in the perioperative setting: clinical consequences and recommendations for practice"],"prefix":"10.1093","volume":"87","author":[{"given":"Moises","family":"Auron","sequence":"first","affiliation":[{"name":"Department of Hospital Medicine, Cleveland Clinic , Cleveland, Ohio, USA"},{"name":"Center for Pediatric Hospital Medicine, Children's Hospital, Cleveland Clinic , Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Harte","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Cleveland Clinic , Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Cleveland Clinic , Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Michota","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Cleveland Clinic , Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,3,25]]},"reference":[{"key":"2023041908313653100_b1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7326\/0003-4819-148-1-200801010-00189","article-title":"Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension","volume":"148","author":"Matchar","year":"2008","journal-title":"Ann Intern Med"},{"key":"2023041908313653100_b2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cardfail.2007.11.008","article-title":"Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Lakhdar","year":"2008","journal-title":"J Card Fail"},{"key":"2023041908313653100_b3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1525-1497.2006.00590.x","article-title":"Angiotensin inhibition after myocardial infarction: does drug class matter?","volume":"21","author":"Winkelmayer","year":"2006","journal-title":"J Gen Intern Med"},{"key":"2023041908313653100_b4","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","article-title":"Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis","volume":"366","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"2023041908313653100_b5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2174\/138161207780618768","article-title":"Role of renin angiotensin system inhibitors in cardiovascular and renal protection: a lesson from clinical trials","volume":"13","author":"Stojiljkovic","year":"2007","journal-title":"Curr Pharm Des"},{"key":"2023041908313653100_b6","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1213\/00000539-199911000-00012","article-title":"Renin angiotensin system antagonists and anesthesia","volume":"89","author":"Colson","year":"1999","journal-title":"Anesth Analg"},{"key":"2023041908313653100_b7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000539-200111000-00008","article-title":"The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function","volume":"93","author":"Cittanova","year":"2001","journal-title":"Anesth Analg"},{"key":"2023041908313653100_b8","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jacc.2009.07.008","article-title":"Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting","volume":"54","author":"Miceli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2023041908313653100_b9","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-Converting Enzyme Inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"key":"2023041908313653100_b10","first-page":"123","article-title":"Angiotensin II receptor blockers","volume":"16","author":"Barreras","year":"2003","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"2023041908313653100_b11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.CIR.102.3.351","article-title":"Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin","volume":"102","author":"Varin","year":"2000","journal-title":"Circulation"},{"key":"2023041908313653100_b12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin system revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J Intern Med"},{"key":"2023041908313653100_b13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/hr.2009.184","article-title":"Reinventing the ACE inhibitors: some old and new implications of ACE inhibition","volume":"33","author":"Hanif","year":"2010","journal-title":"Hypertens Res"},{"key":"2023041908313653100_b14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/HYPERTENSIONAHA.109.145839","article-title":"New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism","volume":"55","author":"Ferrario","year":"2010","journal-title":"Hypertension"},{"key":"2023041908313653100_b15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00109-008-0340-4","article-title":"New angiotensins","volume":"86","author":"Varagic","year":"2008","journal-title":"J Mol Med"},{"key":"2023041908313653100_b16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/1381612033455413","article-title":"Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice","volume":"9","author":"Behnia","year":"2003","journal-title":"Curr Pharm Des"},{"key":"2023041908313653100_b17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1213\/01.ane.0000226099.60493.d9","article-title":"Perioperative management of chronic heart failure","volume":"103","author":"Groban","year":"2006","journal-title":"Anesth Analg"},{"key":"2023041908313653100_b18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.aco.0000174963.35877.81","article-title":"Arginine vasopressin as a rescue vasopressor agent in the operating room","volume":"18","author":"Jochberger","year":"2005","journal-title":"Curr Opin Anaesthesiol"},{"key":"2023041908313653100_b19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/108925320300700111","article-title":"Renin angiotensin aldosterone systems blockade and perioperative left ventricular function","volume":"7","author":"Coriat","year":"2003","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"2023041908313653100_b20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/CIRCULATIONAHA.106.642058","article-title":"Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor","volume":"115","author":"Su","year":"2007","journal-title":"Circulation"},{"key":"2023041908313653100_b21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00109-008-0344-0","article-title":"Genetics of the human renin angiotensin system","volume":"86","author":"Jeunemaitre","year":"2008","journal-title":"J Mol Med"},{"key":"2023041908313653100_b22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000159124","article-title":"The renin-angiotensin-aldosterone system: approaches to guide angiotensin-converting enzyme inhibition in patients with coronary artery disease","volume":"112","author":"Brugts","year":"2009","journal-title":"Cardiology"},{"key":"2023041908313653100_b23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2217\/14622416.10.3.463","article-title":"Significance of genetic polymorphisms of the renin\u2013angiotensin\u2013aldosterone system in cardiovascular and renal disease","volume":"10","author":"Rudnicki","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"Suppl1","key":"2023041908313653100_b24","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.3949\/ccjm.73.Suppl_1.S82","article-title":"Perioperative medication management: a case-based review of general principles","volume":"73","author":"Saber","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"2023041908313653100_b25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2044.1990.tb14697.x","article-title":"Pressor responses to tracheal intubation after sublingual captopril. A pilot study","volume":"45","author":"McCarthy","year":"1990","journal-title":"Anaesthesia"},{"key":"2023041908313653100_b26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00000542-199408000-00006","article-title":"Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction","volume":"81","author":"Coriat","year":"1994","journal-title":"Anesthesiology"},{"key":"2023041908313653100_b27","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1097\/00000539-199912000-00011","article-title":"The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists","volume":"89","author":"Brabant","year":"1999","journal-title":"Anesth Analg"},{"key":"2023041908313653100_b28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000539-200101000-00006","article-title":"Should the angiotensin II antagonists be discontinued before surgery?","volume":"92","author":"Bertrand","year":"2001","journal-title":"Anesth Analg"},{"key":"2023041908313653100_b29","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1213\/01.ANE.0000146521.68059.A1","article-title":"Angiotensin system inhibitors in a general surgical population","volume":"100","author":"Comfere","year":"2005","journal-title":"Anesth Analg"},{"key":"2023041908313653100_b30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00101-007-1177-x","article-title":"Preoperative administration of angiotensin-converting enzyme inhibitors","volume":"56","author":"Schirmer","year":"2007","journal-title":"Anaesthesist"},{"key":"2023041908313653100_b31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF03018973","article-title":"Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors","volume":"47","author":"Licker","year":"2000","journal-title":"Can J Anaesth"},{"key":"2023041908313653100_b32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jhm.323","article-title":"Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period","volume":"3","author":"Rosenman","year":"2008","journal-title":"J Hosp Med"},{"key":"2023041908313653100_b33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.jvca.2007.12.020","article-title":"Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery","volume":"22","author":"Kheterpal","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2023041908313653100_b34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12630-010-9330-4","article-title":"Renin-angiotensin blockade is associated with increased mortality after vascular surgery","volume":"57","author":"Railton","year":"2010","journal-title":"Can J Anaesth"},{"key":"2023041908313653100_b35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1213\/00000539-199206000-00005","article-title":"Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors","volume":"74","author":"Colson","year":"1992","journal-title":"Anesth Analg"},{"key":"2023041908313653100_b36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1213\/00000539-199503000-00007","article-title":"Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass","volume":"80","author":"Tuman","year":"1995","journal-title":"Anesth Analg"},{"key":"2023041908313653100_b37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1010-7940(98)00051-7","article-title":"Effects of angiotensin converting enzyme inhibition on systemic vascular resistance and vasoconstrictor requirements during hypothermic cardiopulmonary bypass","volume":"13","author":"Deakin","year":"1998","journal-title":"Eur J Cardiothorac Surg"},{"key":"2023041908313653100_b38","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on\u2013cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome","volume":"120","author":"Levin","year":"2009","journal-title":"Circulation"},{"key":"2023041908313653100_b39","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.athoracsur.2006.12.032","article-title":"Atrial fibrillation after coronary artery bypass grafting surgery: development of a predictive risk algorithm","volume":"83","author":"Magee","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"2023041908313653100_b40","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-5223(98)70049-2","article-title":"Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent","volume":"116","author":"Argenziano","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023041908313653100_b41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/147323000503300612","article-title":"Effect of pre-operative angiotensin-converting enzyme inhibitors on haemodynamic parameters and vasoconstrictor requirements in patients undergoing off-pump coronary artery bypass surgery","volume":"33","author":"Lee","year":"2005","journal-title":"J Int Med Res"},{"key":"2023041908313653100_b42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-2007-1013172","article-title":"Post-perfusion syndrome and disturbed microcirculation after cardiac surgery: the role of angiotensin-converting-enzyme inhibitors","volume":"47","author":"Boeken","year":"1999","journal-title":"Thorac Cardiovasc Surg"},{"key":"2023041908313653100_b43","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1510\/icvts.2007.174698","article-title":"Should angiotensin converting enzyme inhibitors\/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?","volume":"7","author":"Raja","year":"2008","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2023041908313653100_b44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ahj.2010.05.033","article-title":"Preoperative angiotensin-blocking drug therapy is not associated with atrial fibrillation after cardiac surgery","volume":"160","author":"Rader","year":"2010","journal-title":"Am Heart J"},{"key":"2023041908313653100_b45","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2215\/CJN.05271107","article-title":"Preoperative use of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery","volume":"3","author":"Arora","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023041908313653100_b46","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.athoracsur.2005.03.136","article-title":"Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?","volume":"80","author":"Kincaid","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"2023041908313653100_b47","first-page":"111","volume-title":"Spinal and Epidural Anesthesia","author":"Scavone","year":"2007"},{"key":"2023041908313653100_b48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1034\/j.1399-6576.2003.00175.x","article-title":"ACE inhibition does not exaggerate the blood pressure decrease in the early phase of spinal anaesthesia","volume":"47","author":"Hohne","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"key":"2023041908313653100_b49","first-page":"63","article-title":"Sympathetic blockade by thoracic epidural anaesthesia suppresses renin release in response to hypotension, but activates the vasopressin system","volume":"9","author":"Hopf","year":"1992","journal-title":"Eur J Anaesthesiol"},{"key":"2023041908313653100_b50","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/00000542-199405000-00007","article-title":"Sympathetic neural blockade by thoracic epidural anesthesia suppresses renin release in response to arterial hypotension","volume":"80","author":"Hopf","year":"1994","journal-title":"Anesthesiology"},{"key":"2023041908313653100_b51","first-page":"36","article-title":"Influence of angiotensin-converting enzyme inhibitors during spinal anesthesia","volume":"42","author":"Castanon","year":"1995","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"2023041908313653100_b52","first-page":"16","article-title":"The importance of interrupting angiotensin converting enzyme inhibitor treatment before spinal anaesthesia\u2013a controlled case report","volume":"29","author":"Cozanitis","year":"2004","journal-title":"Anaesthesiol Reanim"},{"key":"2023041908313653100_b53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1157\/13115775","article-title":"Severe hypotension during spinal anesthesia induced by angiotensin-converting enzyme inhibitors (In Spanish).","volume":"130","author":"Pose Reino","year":"2008","journal-title":"Med Clin (Barc)"},{"key":"2023041908313653100_b54","first-page":"796","article-title":"Profound bradycardia and hypotension following spinal anaesthesia in a patient receiving an ACE inhibitor: an important \u2018drug\u2019 interaction?","volume":"16","author":"Williams","year":"1999","journal-title":"Eur J Anaesthesiol"},{"key":"2023041908313653100_b55","first-page":"722","article-title":"Refractory hypotension in a patient chronically treated with a long acting angiotensin-converting enzyme inhibitor","volume":"32","author":"Akinci","year":"2004","journal-title":"Anaesth Intensive Care"},{"key":"2023041908313653100_b56","article-title":"Perioperative cardiovascular medication management","volume-title":"ACP PIER: Perioperative Medication Management","author":"Cohn","year":"2010"},{"key":"2023041908313653100_b57","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/ACO.0b013e32833eeb19","article-title":"Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?","volume":"23","author":"Smith","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"2023041908313653100_b58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00008506-199301000-00003","article-title":"Enalapril premedication attenuates the blood pressure response to tracheal intubation and stabilizes postoperative blood pressure after controlled hypotension with sodium nitroprusside in neurovascular patients","volume":"5","author":"Tohmo","year":"1993","journal-title":"J Neurosurg Anesthesiol"},{"key":"2023041908313653100_b59","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2165\/00003495-200767070-00007","article-title":"Controlled hypotension: a guide to drug choice","volume":"67","author":"Degoute","year":"2007","journal-title":"Drugs"},{"key":"2023041908313653100_b60","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-6576.1996.tb04401.x","article-title":"Angiotensin-converting enzyme inhibitors and anaesthesia","volume":"40","author":"Tohmo","year":"1996","journal-title":"Acta Anaesthesiol Scand"},{"key":"2023041908313653100_b61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/bja\/73.3.303","article-title":"Does the choice of antihypertensive therapy influence haemodynamic responses to induction, laryngoscopy and intubation?","volume":"73","author":"Sear","year":"1994","journal-title":"Br J Anaesth"},{"key":"2023041908313653100_b62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/bja\/83.5.715","article-title":"Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements","volume":"83","author":"Pigott","year":"1999","journal-title":"Br J Anaesth"},{"key":"2023041908313653100_b63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vph.2005.01.012","article-title":"The use of angiotensin-converting enzyme inhibitors in patients undergoing coronary artery bypass graft surgery","volume":"42","author":"Lazar","year":"2005","journal-title":"Vascul Pharmacol"},{"key":"2023041908313653100_b64","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijcard.2007.05.012","article-title":"Effect of renin-angiotensin aldosterone system blockers on postoperative atrial fibrillation","volume":"127","author":"Ozaydin","year":"2008","journal-title":"Int J Cardiol"},{"key":"2023041908313653100_b65","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ejcts.2007.02.010","article-title":"Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III","volume":"31","author":"White","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"2023041908313653100_b66","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by renin-angiotensin system inhibition","volume":"55","author":"Schneider","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2023041908313653100_b67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5152\/akd.2010.039","article-title":"Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction","volume":"10","author":"Ozaydin","year":"2010","journal-title":"Anadolu Kardiyol Derg"},{"key":"2023041908313653100_b68","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/hrt.76.3.207","article-title":"Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery?","volume":"76","author":"Boldt","year":"1996","journal-title":"Heart"},{"key":"2023041908313653100_b69","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2459\/JCM.0b013e32830a6daf","article-title":"Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery","volume":"9","author":"Benedetto","year":"2008","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2023041908313653100_b70","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/bja\/76.5.632","article-title":"Preoperative inhibition of angiotensin-converting enzyme improves systemic and renal haemodynamic changes during aortic abdominal surgery","volume":"76","author":"Licker","year":"1996","journal-title":"Br J Anaesth"},{"key":"2023041908313653100_b71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00000542-199001000-00005","article-title":"Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery","volume":"72","author":"Colson","year":"1990","journal-title":"Anesthesiology"},{"key":"2023041908313653100_b72","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.athoracsur.2008.06.018","article-title":"Preoperative angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting","volume":"86","author":"Benedetto","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2023041908313653100_b73","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/00000542-200306000-00007","article-title":"Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors","volume":"98","author":"Boccara","year":"2003","journal-title":"Anesthesiology"},{"key":"2023041908313653100_b74","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/BF03008216","article-title":"Amiodarone and anaesthesia: Concurrent therapy with ACE inhibitors\u2013an additional cause for concern?","volume":"38","author":"Mackay","year":"1991","journal-title":"Can J Anaesth"},{"key":"2023041908313653100_b75","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/bja\/aem098","article-title":"Diastolic heart failure in anaesthesia and critical care","volume":"98","author":"Pirracchio","year":"2007","journal-title":"Br J Anaesth"},{"key":"2023041908313653100_b76","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.anclin.2009.07.008","article-title":"Diastolic dysfunction, cardiovascular aging, and the anesthesiologist","volume":"27","author":"Sanders","year":"2009","journal-title":"Anesthesiol Clin"},{"key":"2023041908313653100_b77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejcts.2008.10.038","article-title":"Management of diastolic heart failure following cardiac surgery","volume":"35","author":"Alsaddique","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"2023041908313653100_b78","first-page":"II_556","article-title":"Unprecedented renal responses to direct blockade of the renin-angiotensin-system with aliskiren, a novel renin inhibitor","volume":"116","author":"Fischer","year":"2007","journal-title":"Circulation"},{"key":"2023041908313653100_b79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jacc.2007.10.027","article-title":"Renin inhibition in hypertension","volume":"51","author":"Gradman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2023041908313653100_b80","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.108.787630","article-title":"Aliskiren","volume":"118","author":"Brown","year":"2008","journal-title":"Circulation"},{"key":"2023041908313653100_b81","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2146\/ajhp070529","article-title":"Aliskiren","volume":"65","author":"Daugherty","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"2023041908313653100_b82","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.bcp.2009.05.018","article-title":"The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality","volume":"78","author":"Abassi","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"2023041908313653100_b83","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1345\/aph.1P338","article-title":"Spironolactone management of resistant hypertension","volume":"44","author":"Marrs","year":"2010","journal-title":"Ann Pharmacother"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/87\/1029\/472\/50018990\/postgradmedj-87-472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/87\/1029\/472\/50018990\/postgradmedj-87-472.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T08:37:43Z","timestamp":1681893463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/87\/1029\/472\/7040786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,25]]},"references-count":83,"journal-issue":{"issue":"1029","published-online":{"date-parts":[[2011,3,25]]},"published-print":{"date-parts":[[2011,7,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2010.112987","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,7]]},"published":{"date-parts":[[2011,3,25]]}}}